As DMD progresses, patients begin to lose regenerative capabilities, therefore an orchestrated action of both enhanced differentiation and increased utrophin expression may be advantageous in a disease setting25,65,75. The gene discussed is UTRN; the disease is Duchenne muscular dystrophy.